224 related articles for article (PubMed ID: 22729868)
1. Does familial clustering of risk factors for long-term diabetic complications leave any place for genes that act independently?
Paterson AD; Bull SB
J Cardiovasc Transl Res; 2012 Aug; 5(4):388-98. PubMed ID: 22729868
[TBL] [Abstract][Full Text] [Related]
2. A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose.
Paterson AD; Waggott D; Boright AP; Hosseini SM; Shen E; Sylvestre MP; Wong I; Bharaj B; Cleary PA; Lachin JM; ; Below JE; Nicolae D; Cox NJ; Canty AJ; Sun L; Bull SB;
Diabetes; 2010 Feb; 59(2):539-49. PubMed ID: 19875614
[TBL] [Abstract][Full Text] [Related]
3. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
Diabetes; 1997 Nov; 46(11):1829-39. PubMed ID: 9356033
[TBL] [Abstract][Full Text] [Related]
4. Prediction of the risk to develop diabetes-related late complications by means of the glucose pentagon model: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring study.
Thomas A; Heinemann L
J Diabetes Sci Technol; 2012 May; 6(3):572-80. PubMed ID: 22768888
[TBL] [Abstract][Full Text] [Related]
5. Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes.
Syreeni A; Sandholm N; Cao J; Toppila I; Maahs DM; Rewers MJ; Snell-Bergeon JK; Costacou T; Orchard TJ; Caramori ML; Mauer M; Klein BEK; Klein R; Valo E; Parkkonen M; Forsblom C; Harjutsalo V; Paterson AD; ; Groop PH;
Diabetes; 2019 Apr; 68(4):858-867. PubMed ID: 30674623
[TBL] [Abstract][Full Text] [Related]
6. An Observational Study of the Equivalence of Age and Duration of Diabetes to Glycemic Control Relative to the Risk of Complications in the Combined Cohorts of the DCCT/EDIC Study.
Bebu I; Braffett BH; Schade D; Sivitz W; Malone JI; Pop-Busui R; Lorenzi GM; Lee P; Trapani VR; Wallia A; Herman WH; Lachin JM;
Diabetes Care; 2020 Oct; 43(10):2478-2484. PubMed ID: 32788280
[TBL] [Abstract][Full Text] [Related]
7. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs and diabetic complications.
Natarajan R; Putta S; Kato M
J Cardiovasc Transl Res; 2012 Aug; 5(4):413-22. PubMed ID: 22552970
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of non-genetic predictors and genetic factors of glycated haemoglobin in type 1 diabetes one year after diagnosis.
Gloaguen E; Bendelac N; Nicolino M; Julier C; Mathieu F
Diabetes Metab Res Rev; 2018 Nov; 34(8):e3051. PubMed ID: 30063815
[TBL] [Abstract][Full Text] [Related]
10. The association of hemoglobin A1c with the prevalence of stenosing flexor tenosynovitis.
Vance MC; Tucker JJ; Harness NG
J Hand Surg Am; 2012 Sep; 37(9):1765-9. PubMed ID: 22854253
[TBL] [Abstract][Full Text] [Related]
11. Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.
Chen Z; Miao F; Paterson AD; Lachin JM; Zhang L; Schones DE; Wu X; Wang J; Tompkins JD; Genuth S; Braffett BH; Riggs AD; ; Natarajan R
Proc Natl Acad Sci U S A; 2016 May; 113(21):E3002-11. PubMed ID: 27162351
[TBL] [Abstract][Full Text] [Related]
12. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
[TBL] [Abstract][Full Text] [Related]
13. HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes.
Hietala K; Wadén J; Forsblom C; Harjutsalo V; Kytö J; Summanen P; Groop PH;
Diabetologia; 2013 Apr; 56(4):737-45. PubMed ID: 23314044
[TBL] [Abstract][Full Text] [Related]
14. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients.
Tarnow L; Kjeld T; Knudsen E; Major-Pedersen A; Parving HH
Diabetologia; 2000 Jun; 43(6):794-9. PubMed ID: 10907125
[TBL] [Abstract][Full Text] [Related]
15. Chromatin modifications associated with diabetes.
Keating ST; El-Osta A
J Cardiovasc Transl Res; 2012 Aug; 5(4):399-412. PubMed ID: 22639343
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of the Diabetic Retinopathy and Genetic Factors Significance in the Development of Diabetic Retinopathy in Patients with Diabetes Mellitus type I and II in Slovakia (DIARET SK study). Overview of Actual Findings and Design of the Epidemiological DIARET SK Study].
Krásnik V; Štefaničková J; Fabková J; Bucková D; Helbich M
Cesk Slov Oftalmol; 2015 Sep; 71(5):237-42. PubMed ID: 26782726
[TBL] [Abstract][Full Text] [Related]
17. Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden).
Nordwall M; Abrahamsson M; Dhir M; Fredrikson M; Ludvigsson J; Arnqvist HJ
Diabetes Care; 2015 Feb; 38(2):308-15. PubMed ID: 25510400
[TBL] [Abstract][Full Text] [Related]
18. Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes.
Jain R; Özgümüş T; Jensen TM; du Plessis E; Keindl M; Møller CL; Falhammar H; Nyström T; Catrina SB; Jörneskog G; Jessen LE; Forsblom C; Haukka JK; Groop PH; Rossing P; Groop L; Eliasson M; Eliasson B; Brismar K; Al-Majdoub M; Nilsson PM; Taskinen MR; Ferrannini E; Spégel P; Berg TJ; Lyssenko V
Sci Rep; 2020 Jul; 10(1):11561. PubMed ID: 32665614
[TBL] [Abstract][Full Text] [Related]
19. The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes.
Möllsten A; Jorsal A; Lajer M; Vionnet N; Tarnow L
Diabetologia; 2009 Dec; 52(12):2590-3. PubMed ID: 19834686
[TBL] [Abstract][Full Text] [Related]
20. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.
Monnier VM; Bautista O; Kenny D; Sell DR; Fogarty J; Dahms W; Cleary PA; Lachin J; Genuth S
Diabetes; 1999 Apr; 48(4):870-80. PubMed ID: 10102706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
